TSH Biopharm Corporation Limited (TPEX:8432)
Taiwan · Delayed Price · Currency is TWD 50.90
-0.30 (-0.59%)
At close: Mar 26, 2026
TSH Biopharm Corporation Market Cap
TSH Biopharm Corporation has a market cap or net worth of 1.95 billion as of March 26, 2026. Its market cap has decreased by -11.63% in one year.
Market Cap
1.95B
Enterprise Value
1.32B
Revenue
1.34B
Ranking
n/a
PE Ratio
14.06
Stock Price
50.90
Market Cap Chart
Since June 16, 2011, TSH Biopharm Corporation's market cap has decreased from 1.96B to 1.95B, a decrease of -0.40%. That is a compound annual growth rate of -0.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 1.97B | -12.48% |
| Dec 31, 2025 | 2.25B | -4.57% |
| Dec 31, 2024 | 2.35B | 21.87% |
| Dec 29, 2023 | 1.93B | 5.78% |
| Dec 30, 2022 | 1.83B | 6.85% |
| Dec 30, 2021 | 1.71B | -24.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merdury Biopharmaceutical | 3.35B |
| Maywufa Company | 2.90B |
| Allied Biotech | 2.62B |
| PhytoHealth | 2.60B |
| Johnson Chemical Pharmaceutical Works | 2.47B |
| Tien Liang BioTech | 1.63B |
| InnoPharmax | 1.55B |
| GeneFerm Biotechnology | 1.54B |